Literature DB >> 11246880

Preferential channeling of energy fuels toward fat rather than muscle during high free fatty acid availability in rats.

R Fabris1, E Nisoli, A M Lombardi, C Tonello, R Serra, M Granzotto, I Cusin, F Rohner-Jeanrenaud, G Federspil, M O Carruba, R Vettor.   

Abstract

The preferential channeling of different fuels to fat and changes in the transcription profile of adipose tissue and skeletal muscle are poorly understood processes involved in the pathogenesis of obesity and insulin resistance. Carbohydrate and lipid metabolism may play relevant roles in this context. Freely moving lean Zucker rats received 3- and 24-h infusions of Intralipid (Pharmacia and Upjohn, Milan, Italy) plus heparin, or saline plus heparin, to evaluate how an increase in free fatty acids (nonesterified fatty acid [NEFA]) modulates fat tissue and skeletal muscle gene expression and thus influences fuel partitioning. Glucose uptake was determined in various tissues at the end of the infusion period by means of the 2-deoxy-[1-3H]-D-glucose technique after a euglycemic-hyperinsulinemic clamp: high NEFA levels markedly decreased insulin-mediated glucose uptake in red fiber-type muscles but enhanced glucose utilization in visceral fat. Using reverse transcriptase-polymerase chain reaction and Northern blotting analyses, the mRNA expression of fatty acid translocase (FAT)/CD36, GLUT4, tumor necrosis factor (TNF)-alpha, peroxisome proliferator-activated receptor (PPAR)-gamma, leptin, uncoupling protein (UCP)-2, and UCP-3 was investigated in different fat depots and skeletal muscles before and after the study infusions. GLUT4 mRNA levels significantly decreased (by approximately 25%) in red fiber-type muscle (soleus) and increased (by approximately 45%) in visceral adipose tissue. Furthermore, there were marked increases in FAT/CD36, TNF-alpha, PPAR-gamma, leptin, UCP2, and UCP3 mRNA levels in the visceral fat and muscle of the treated animals in comparison with those measured in the saline-treated animals. These data suggest that the in vivo gene expression of FAT/CD36, GLUT4, TNF-alpha, PPAR-gamma, leptin, UCP2, and UCP3 in visceral fat and red fiber-type muscle are differently regulated by circulating lipids and that selective insulin resistance seems to favor, at least in part, a prevention of fat accumulation in tissues not primarily destined for fat storage, thus contributing to increased adiposity and the development of a prediabetic syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11246880     DOI: 10.2337/diabetes.50.3.601

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

Review 1.  Peroxisome proliferator activated receptors, fatty acids and muscle insulin resistance.

Authors:  Edward Kraegen; Gregory Cooney; Ji-Ming Ye; Stuart Furler
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

2.  Temporal profiling of the transcriptional basis for the development of corticosteroid-induced insulin resistance in rat muscle.

Authors:  Richard R Almon; Debra C Dubois; Jin Y Jin; William J Jusko
Journal:  J Endocrinol       Date:  2005-01       Impact factor: 4.286

3.  Regulation of fatty acid transport: from transcriptional to posttranscriptional effects.

Authors:  Adrian Chabowski; Jan Górski; Arend Bonen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-07       Impact factor: 3.000

4.  CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood.

Authors:  Victor A Drover; Mohammad Ajmal; Fatiha Nassir; Nicholas O Davidson; Andromeda M Nauli; Daisy Sahoo; Patrick Tso; Nada A Abumrad
Journal:  J Clin Invest       Date:  2005-04-07       Impact factor: 14.808

5.  Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha ) and mitochondrial function by MEF2 and HDAC5.

Authors:  Michael P Czubryt; John McAnally; Glenn I Fishman; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

6.  Intralipid/heparin infusion suppresses serum leptin in humans.

Authors:  P Garcia-Lorda; Wendy Nash; Ansley Roche; F-X Pi-Sunyer; B Laferrere
Journal:  Eur J Endocrinol       Date:  2003-06       Impact factor: 6.664

7.  Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity.

Authors:  Erin R Cernkovich; Jianbei Deng; Michael C Bond; Terry P Combs; Joyce B Harp
Journal:  Endocrinology       Date:  2007-12-20       Impact factor: 4.736

8.  Changes in cardiac substrate transporters and metabolic proteins mirror the metabolic shift in patients with aortic stenosis.

Authors:  Lisa C Heather; Neil J Howell; Yaso Emmanuel; Mark A Cole; Michael P Frenneaux; Domenico Pagano; Kieran Clarke
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

9.  Alterations in Glucose Metabolism During the Transition to Heart Failure: The Contribution of UCP-2.

Authors:  Hanna Sarah Kutsche; Rolf Schreckenberg; Martin Weber; Christine Hirschhäuser; Susanne Rohrbach; Ling Li; Bernd Niemann; Rainer Schulz; Klaus-Dieter Schlüter
Journal:  Cells       Date:  2020-02-27       Impact factor: 6.600

10.  Caloric restriction decreases orthostatic tolerance independently from 6° head-down bedrest.

Authors:  John P Florian; Friedhelm J Baisch; Martina Heer; James A Pawelczyk
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.